Invalid Symbol

Stock Research for CGEN

CGEN
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

CGEN Stock Chart & Research Data

The CGEN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CGEN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CGEN Due diligence Resources & Stock Charts

The CGEN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CGEN Detailed Price Forecast - CNN Money CNN View CGEN Detailed Summary - Google Finance
Yahoo View CGEN Detailed Summary - Yahoo! Finance Zacks View CGEN Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View CGEN Trends & Analysis - Trade-Ideas Barrons View CGEN Major Holders - Barrons
NASDAQ View CGEN Call Transcripts - NASDAQ Seeking View CGEN Breaking News & Analysis - Seeking Alpha
Spotlight View CGEN Annual Report - CompanySpotlight.com OTC Report View CGEN OTC Short Report - OTCShortReport.com
TradeKing View CGEN Fundamentals - TradeKing Charts View CGEN SEC Filings - Bar Chart
WSJ View Historical Prices for CGEN - The WSJ Morningstar View Performance/Total Return for CGEN - Morningstar
MarketWatch View the Analyst Estimates for CGEN - MarketWatch CNBC View the Earnings History for CGEN - CNBC
StockMarketWatch View the CGEN Earnings - StockMarketWatch MacroAxis View CGEN Buy or Sell Recommendations - MacroAxis
Bullish View the CGEN Bullish Patterns - American Bulls Short Pains View CGEN Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View CGEN Stock Mentions - StockTwits PennyStocks View CGEN Stock Mentions - PennyStockTweets
Twitter View CGEN Stock Mentions - Twitter Invest Hub View CGEN Investment Forum News - Investor Hub
Yahoo View CGEN Stock Mentions - Yahoo! Message Board Seeking Alpha View CGEN Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for CGEN - SECform4.com Insider Cow View Insider Transactions for CGEN - Insider Cow
CNBC View CGEN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CGEN - OTC Markets
Yahoo View Insider Transactions for CGEN - Yahoo! Finance NASDAQ View Institutional Holdings for CGEN - NASDAQ


Stock Charts

FinViz View CGEN Stock Insight & Charts - FinViz.com StockCharts View CGEN Investment Charts - StockCharts.com
BarChart View CGEN Stock Overview & Charts - BarChart Trading View View CGEN User Generated Charts - Trading View


Latest Financial News for CGEN

Compugen Ltd. to Host Earnings Call
Posted on Wednesday February 21, 2018

NEW YORK, NY / ACCESSWIRE / February 21, 2018 / Compugen Ltd. (NASDAQ: CGEN ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 21, 2018, at 10:00 AM Eastern Time. ...


Compugen reports 4Q loss
Posted on Wednesday February 21, 2018

The Holon, Israel-based company said it had a loss of 18 cents per share. For the year, the company reported that its loss widened to $37.1 million, or 72 cents per share. The company's shares closed at ...


Compugen Reports Fourth Quarter and Full Year 2017 Results
Posted on Wednesday February 21, 2018

Phase 1 Trial for COM701 Expected to Start in 2018 Bayer in Late Stage Preclinical Development of CGEN-15001T Program HOLON, Israel , Feb. 21, 2018 /PRNewswire/ -- Compugen Ltd. ( NASDAQ: CGEN ), a leader ...


Wired News – Compugen Reports Publication of Discovery and Validation of ILDR2 as A Novel Immune Checkpoint and Its Use for Auto-Immune Diseases
Posted on Thursday February 08, 2018

Stock Monitor: Array BioPharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / February 08, 2018 / Active-Investors.com has just released a free research report on Compugen Ltd (NASDAQ: CGEN ). If you ...


Dr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew ...
PR Newswire (press release) - Apr 6, 2016
The Company also announced that Drew Pardoll, M.D., Ph.D., Abeloff Professor of Oncology, Medicine, Pathology, and Molecular Biology and Genetics and Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Sidney Kimmel Cancer Center ...

Compugen's (CGEN) CEO Anat Cohen-Dayag on Q4 2017 Results - Earnings Call ...
Seeking Alpha - Feb 21, 2018
With me from Compugen are Dr. Anat Cohen-Dayag, President and CEO; and Ari Krashin, CFO and COO and Dr. John Hunter, Vice President, Antibody R&D and Head of our USA. Before we begin, I would like to read the following regarding forward-looking ...

Compugen's (CGEN) CEO Anat Cohen-Dayag on Q3 2017 Results - Earnings Call ...
Seeking Alpha - Nov 7, 2017
I would like to welcome everyone to our quarterly earnings update. I will focus in my prepared comments today on the progress we have made during the last quarter with respect to our pipeline program, the development path and potential impact both on ...

28 Stocks Moving In Monday's Pre-Market Session
Benzinga - Oct 9, 2017
Cleantech Solutions International Inc (NASDAQ: CLNT) rose 20.2 percent to $3.99 in pre-market trading after the company reported an exclusivity agreement for the potential takeover of Inspirit Studio.

Enter a stock symbol to view the stock details.